EM SAQs · Acute decompensated heart failure
Acute pulmonary oedema
An ACEM-style SAQ on the management of acute pulmonary oedema.
On this page
Study tools
Target exams
Model answer
Reveal model answerShowHide
Classify: wet (crackles) and warm (warm peripheries) — Nohria profile B, the largest profile in the 452-patient cohort; congested profiles carried a higher risk of death or urgent transplantation (HR 2.48).[7] Oxygen and NIV: oxygen is indicated because SpO2 is under 90 percent (not routinely in non-hypoxaemic patients). Respiratory distress (RR over 25, SpO2 under 90 percent) means non-invasive positive pressure ventilation as soon as possible, monitoring BP because raised intrathoracic pressure reduces preload. 3CPO: NIV gave faster improvement in dyspnoea and metabolic disturbance than oxygen, with no difference in 7-day mortality. Intubate for progressive respiratory failure despite NIV.[1][2] Vasodilator: SBP is over 110 mmHg, so an IV vasodilator may be considered — nitrate bolus then infusion, or repeated boluses (nitroglycerin 1–2 mg boluses in severely hypertensive acute pulmonary oedema). Cotter: the high-dose isosorbide dinitrate arm needed mechanical ventilation in 13 vs 40 percent.[1][4] Diuretic: IV loop diuretic (oral absorption may be reduced by bowel oedema). DOSE: 1x vs 2.5x the previous oral dose and bolus vs infusion did not differ for the co-primary endpoints. Check the response: urine sodium under 50–70 mEq/L at 2 h and/or urine output under 100–150 mL/h in the first 6 h is insufficient — double the dose.[5][3] Precipitant: in OPTIMIZE-HF the commonest identified were pneumonia/respiratory process, ischaemia and arrhythmia; non-adherence, hypertension and worsening renal function were also captured.[8] Avoid routine morphine — in ADHERE it was an independent predictor of mortality after risk adjustment.[6]
References8ShowHide
- [1]McDonagh TA, Metra M, Adamo M, et al. 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure. European heart journal, 2021.PMID 34447992
- [2]Gray A, Goodacre S, Newby DE, et al. Noninvasive ventilation in acute cardiogenic pulmonary edema. The New England journal of medicine, 2008.PMID 18614781
- [3]Felker GM, Lee KL, Bull DA, et al. Diuretic strategies in patients with acute decompensated heart failure. The New England journal of medicine, 2011.PMID 21366472
- [4]Cotter G, Metzkor E, Kaluski E, et al. Randomised trial of high-dose isosorbide dinitrate plus low-dose furosemide versus high-dose furosemide plus low-dose isosorbide dinitrate in severe pulmonary oedema. Lancet (London, England), 1998.PMID 9482291
- [5]Mullens W, Damman K, Harjola VP, et al. The use of diuretics in heart failure with congestion - a position statement from the Heart Failure Association of the European Society of Cardiology. European journal of heart failure, 2019.PMID 30600580
- [6]Peacock WF, Hollander JE, Diercks DB, et al. Morphine and outcomes in acute decompensated heart failure: an ADHERE analysis. Emergency medicine journal : EMJ, 2008.PMID 18356349
- [7]Nohria A, Tsang SW, Fang JC, et al. Clinical assessment identifies hemodynamic profiles that predict outcomes in patients admitted with heart failure. Journal of the American College of Cardiology, 2003.PMID 12767667
- [8]Fonarow GC, Abraham WT, Albert NM, et al. Factors identified as precipitating hospital admissions for heart failure and clinical outcomes: findings from OPTIMIZE-HF. Archives of internal medicine, 2008.PMID 18443260